NASDAQ:PETQ

PetIQ (PETQ) Stock Forecast, Price & News

$19.56

-0.36 (-1.81%)

(As of 09/25/2023 ET)

Compare

Today's Range: $19.35
▼
$20.17
50-Day Range: $15.98
▼
$20.71
52-Week Range: $6.66
▼
$20.86

Volume: 288,828 shs
Average Volume: 266,287 shs
Market Capitalization: $575.46 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $24.75

PetIQ MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 26.5% Upside
$24.75 Price Target
Short Interest: Bearish
5.64% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.03
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 54.00%
From $0.50 to $0.77 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

650th out of 962 stocks

Drugs, Proprietaries, & Sundries Industry

7th out of 7 stocks

3.5

Analyst's Opinion

Consensus Rating
PetIQ has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $24.75, PetIQ has a forecasted upside of 26.5% from its current price of $19.56.
Amount of Analyst Coverage
PetIQ has only been the subject of 2 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
5.64% of the float of PetIQ has been sold short.
Short Interest Ratio / Days to Cover
PetIQ has a short interest ratio ("days to cover") of 5.6.
Change versus previous month
Short interest in PetIQ has recently increased by 15.91%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
PetIQ does not currently pay a dividend.
Dividend Growth
PetIQ does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PETQ.

3.3

News and Social Media Coverage

News Sentiment
PetIQ has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for PetIQ this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for PETQ on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
2 people have added PetIQ to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, PetIQ insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 9.30% of the stock of PetIQ is held by insiders.
Percentage Held by Institutions
87.10% of the stock of PetIQ is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for PetIQ are expected to grow by 54.00% in the coming year, from $0.50 to $0.77 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of PetIQ is -15.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of PetIQ is -15.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
PetIQ has a PEG Ratio of 4.95. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
PetIQ has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About PetIQ (NASDAQ:PETQ) Stock

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

PETQ Price History

30 days | 90 days | 365 days | Advanced Chart

PETQ Stock News Headlines

September 25, 2023 | finance.yahoo.com

PetIQ (PETQ) Moves 5.7% Higher: Will This Strength Last?

September 24, 2023 | americanbankingnews.com

PetIQ (NASDAQ:PETQ) Trading 4.9% Higher

September 26, 2023 | Legacy Research (Ad)

Watch SHOCKING Footage of AI Facility with Ties to Elon Musk

I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.

September 8, 2023 | msn.com

Lake Street Initiates Coverage of PetIQ Inc - (PETQ) with Buy Recommendation

September 7, 2023 | finance.yahoo.com

Analysts Expect PetIQ, Inc. (NASDAQ:PETQ) To Breakeven Soon

August 23, 2023 | msn.com

PetIQ: Well-Positioned To Grow And Capitalize On The Pet Economy

August 15, 2023 | msn.com

Benchmark Reiterates PetIQ Inc - (PETQ) Buy Recommendation

August 10, 2023 | seekingalpha.com

PetIQ, Inc. 2023 Q2 - Results - Earnings Call Presentation

September 26, 2023 | Legacy Research (Ad)

Watch SHOCKING Footage of AI Facility with Ties to Elon Musk

August 8, 2023 | washingtonpost.com

PetIQ: Q2 Earnings Snapshot

August 8, 2023 | msn.com

PetIQ (PETQ) Q2 Earnings and Revenues Top Estimates

August 8, 2023 | finance.yahoo.com

PetIQ, Inc. Reports Second Quarter 2023 Financial Results

August 5, 2023 | money.usnews.com

PetIQ Inc - Ordinary Shares - Class A

August 2, 2023 | finance.yahoo.com

PetIQ, Inc. Appoints John Pearson to Executive Vice President, Services & Manufactured Products

July 28, 2023 | finance.yahoo.com

Positive Signs As Multiple Insiders Buy PetIQ Stock

July 21, 2023 | msn.com

PETS vs. PETQ: Which Pet Care Stock is Better?

July 20, 2023 | finance.yahoo.com

PetIQ, Inc. to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

July 6, 2023 | msn.com

PetIQ Inc - (PETQ) Price Target Increased by 5.63% to 25.50

June 28, 2023 | finance.yahoo.com

PetIQ (NASDAQ:PETQ) shareholders have endured a 57% loss from investing in the stock three years ago

June 22, 2023 | seekingalpha.com

PetIQ: Steady Growth Play

June 21, 2023 | seekingalpha.com

PetIQ: Looking Smarter, If Margins Return

June 1, 2023 | finance.yahoo.com

PetIQ, Inc. to Participate in Two Upcoming June Investor Conferences

May 25, 2023 | finance.yahoo.com

We Like These Underlying Return On Capital Trends At PetIQ (NASDAQ:PETQ)

May 10, 2023 | msn.com

Earnings Outlook For PetIQ

May 10, 2023 | sfgate.com

PetIQ: Q1 Earnings Snapshot

May 9, 2023 | finance.yahoo.com

PetIQ (PETQ) Tops Q1 Earnings and Revenue Estimates

April 18, 2023 | finance.yahoo.com

PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023

See More Headlines

Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

PETQ Company Calendar

Last Earnings: 8/08/2023
Today: 9/25/2023
Next Earnings (Estimated): 11/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Drugs, proprietaries, & sundries
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:PETQ
CUSIP: N/A
CIK: 1668673
Web: www.petiq.com
Phone: (208) 939-8900
Fax: N/A
Employees: 1,888
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $24.75
High Stock Price Forecast: $30.00
Low Stock Price Forecast: $16.00
Forecasted Upside/Downside: +26.5%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.28)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 39.12
P/E Growth: 4.95
Net Income: $-48,210,000.00
Net Margins: -3.68%
Pretax Margin: -3.60%
Return on Equity: 8.53%
Return on Assets: 2.25%

Debt

Debt-to-Equity Ratio: 1.87
Current Ratio: 2.20
Quick Ratio: 1.46

Sales & Book Value

Annual Sales: $921.51 million
Price / Sales: 0.62
Cash Flow: $3.00 per share
Price / Cash Flow: 6.51
Book Value: $7.25 per share
Price / Book: 2.70

Miscellaneous

Outstanding Shares: 29,420,000
Free Float: 26,686,000
Market Cap: $575.46 million
Optionable: Optionable
Beta: 1.93

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. McCord Christensen (Age 51)
Chairman & CEO

Mr. Michael A. Smith (Age 45)
Pres & COO
Comp: $1.34M

Mr. Zvi Glasman (Age 59)
Chief Financial Officer
Comp: $1.06M

William J. Carter
Exec. VP & Gen. Counsel

Mr. John Pearson
Exec. VP of Services & Manufactured Products

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

PETQ Stock - Frequently Asked Questions

Should I buy or sell PetIQ stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PETQ shares.
View PETQ analyst ratings or view top-rated stocks.
What is PetIQ's stock price forecast for 2023?: 3 Wall Street analysts have issued 1 year price objectives for PetIQ's shares. Their PETQ share price forecasts range from $16.00 to $30.00. On average, they expect the company's stock price to reach $24.75 in the next year. This suggests a possible upside of 26.5% from the stock's current price.
View analysts price targets for PETQ or view top-rated stocks among Wall Street analysts.
How have PETQ shares performed in 2023?: PetIQ's stock was trading at $9.22 on January 1st, 2023. Since then, PETQ stock has increased by 112.1% and is now trading at $19.56.
View the best growth stocks for 2023 here.
When is PetIQ's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our PETQ earnings forecast.
How were PetIQ's earnings last quarter?: PetIQ, Inc. (NASDAQ:PETQ) posted its earnings results on Tuesday, August, 8th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.18 by $0.19. The company had revenue of $314.55 million for the quarter, compared to analyst estimates of $274.19 million. PetIQ had a negative net margin of 3.68% and a positive trailing twelve-month return on equity of 8.53%.
What ETFs hold PetIQ's stock?: ETFs with the largest weight of PetIQ (NASDAQ:PETQ) stock in their portfolio include ProShares Pet Care ETF (PAWZ).Invesco Russell 2000 Dynamic Multifactor ETF (OMFS).
What guidance has PetIQ issued on next quarter's earnings?: PetIQ issued an update on its third quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $220.00 million-$240.00 million, compared to the consensus revenue estimate of $226.90 million.
What is Cord Christensen's approval rating as PetIQ's CEO?: 10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

What other stocks do shareholders of PetIQ own?: Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).
When did PetIQ IPO?: (PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.
What is PetIQ's stock symbol?: PetIQ trades on the NASDAQ under the ticker symbol "PETQ."
Who are PetIQ's major shareholders?: PetIQ's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.11%), Aristotle Capital Boston LLC (4.37%), Boston Partners (3.73%), Nepsis Inc. (3.26%), Goldman Sachs Group Inc. (2.73%) and Brandywine Global Investment Management LLC (2.58%). Insiders that own company stock include Allan Hall, John Newland, Mark L First, Mccord Christensen, Michael A Smith, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis and Zvi Glasman.
View institutional ownership trends.
How do I buy shares of PetIQ?: Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is PetIQ's stock price today?: One share of PETQ stock can currently be purchased for approximately $19.56.
How much money does PetIQ make?: PetIQ (NASDAQ:PETQ) has a market capitalization of $575.46 million and generates $921.51 million in revenue each year. The company earns $-48,210,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis.
How many employees does PetIQ have?: The company employs 1,888 workers across the globe.
How can I contact PetIQ?: PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The official website for the company is www.petiq.com. The company can be reached via phone at (208) 939-8900 or via email at jeff.sonnek@icrinc.com.

This page (NASDAQ:PETQ) was last updated on 9/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial